
BIOX Stock Forecast & Price Target
BIOX Analyst Ratings
Bulls say
Bioceres Crop Solutions demonstrates a positive outlook due to its strong performance outside of Argentina, particularly in the crop protection segment, which continues to gain traction in international markets. The company is well-positioned to benefit from a potential turnaround in Argentine farmer demand, while also capitalizing on robust international opportunities for its HB4 wheat in regions such as the US, Brazil, and Australia. Additionally, the momentum in bio-protection products and increased adjuvant sales in Brazil further supports Bioceres' capacity for revenue growth amidst challenges in the domestic market.
Bears say
Bioceres Crop Solutions is facing a significant decline in revenues across key segments, primarily due to weaker demand for Crop Protection and Crop Nutrition solutions in Argentina, which has been compounded by the company's transition to a licensing-based model that has reduced revenue from HB4-related sales. Crop Nutrition revenue decreased approximately 34% year-over-year to around $25 million, reflecting softer demand and pricing pressures, particularly in the micro-beaded fertilizer markets, attributed to reduced corn acreage throughout FY25. Additionally, revenues from Seed and Integrated products plummeted approximately 75% year-over-year to about $8 million as the company restructured its HB4 program, effectively exiting seed production and commercial sales.
This aggregate rating is based on analysts' research of Bioceres Crop Solutions Corp and is not a guaranteed prediction by Public.com or investment advice.
BIOX Analyst Forecast & Price Prediction
Start investing in BIOX
Order type
Buy in
Order amount
Est. shares
0 shares